Novel 99mTc radiopharmaceuticals with bifunctional chelating agents

详细信息    查看全文

• 作者：1. Burnazyan Federal Medical Biophysical Center ; Federal Medicobiological Agency of Russia ; ul. Zhivopisnaya 46 ; Moscow ; 123182 Russia
• 关键词：technetium ; 99m – ; radiopharmaceuticals – ; bifunctional chelating agents
• 刊名：Radiochemistry
• 出版年：2011
• 出版时间：August 2011
• 年：2011
• 卷：53
• 期：4
• 页码：341-353
• 全文大小：392.2 KB
• 参考文献：1. Schwochau, K., Technetium Chemistry and Radiopharmaceutical Applications, Weinheim (Germany), Wiley-VCH, 2000.
  2. Welch, M.J. and Redvanly, C.S., Handbook of Radiopharmaceuticals. Radiochemistry and Applications, New York (USA): Wiley, 2003.
  3. Tait, J.F., Smith, C., and Gibson, D.F., Bioconjugate Chem., 2002, vol. 13, pp. 1119–1123.
  4. Liu, S., Edwards, D.S., and Barrett, J.A., Bioconjugate Chem., 1997, vol. 8, pp. 621–636.
  5. Mendez-Rojasy, M.A., Kharisov, B.I., and Tsivadze, A.Yu., J. Coord. Chem., 2006, vol. 59, no. 1, pp. 1–63.
  6. Liu, S., Chem. Soc. Rev., 2004, vol. 33, pp. 445–461.
  7. Alberto, R., in Comprehensive Coordination Chemistry II, 2004, vol. 5, pp. 127–270.
  8. King, R.C., Surfraz, B.-U., Biagini, S.C.G., et al., Dalton Trans., 2007, no. 43, pp. 4998–5007.
  9. Hirai, M., Ishizuka, J., Hirai, A., et al., Life Sci., 1993, vol. 53, pp. 1859–1965.
  10. Blankenberg, F.G. and Strauss, H.W., Quart. J. Nucl. Med. Mol. Imag., 2007, vol. 51, pp. 99–110.
  11. Abram, U. and Alberto, R., J. Braz. Chem. Soc., 2006, vol. 17, no. 8, pp. 1486–1500.
  12. Hnatowich, D.J., Layne, W.W., and Childs, R.L., Int. J. Appl. Radiat. Isot., 1982, vol. 33, pp. 327–332.
  13. Hermanson, G.T., Bioconjugate Techniques, Rockford, Illinois (USA): Elsevier, 2008, 2nd ed.
  14. Trubetskoy, V.S. and Torchilin, V.P., Anal. Biochem., 1995, vol. 229, no. 2, pp. 345–347.
  15. Liu, S. and Edwards, D.S., Bioconjugate Chem., 2001, vol. 12, pp. 7–34.
  16. Subramanian, R., Colony, J., Shaban, S., et al., Bioconjugate Chem., 1992, vol. 3, no. 3, pp. 248–255.
  17. Fritzberg, A.R., Kasina, S., Eshima, D., and Johnson, D.L., J. Nucl. Med., 1986, vol. 27, pp. 111–116.
  18. Winnard, P., Jr., Chang, F., Rusckowski, M., et al., Nucl. Med. Biol., 1997, vol. 24, pp. 425–432.
  19. Abrams, M.J., Juweid, M., tenKate, C.I., et al., J. Nucl. Med., 1990, vol. 31, pp. 2022–2028.
  20. Yokoyama, A., Horiuchi, K., and Arano, Y., in 99m Tc Labelled Peptides for Imaging of Peripheral Receptors: Final Report of a Coordinated Research Project 1995–1999, Vienna (Austria): IAEA, 2001, pp. 65–81.
  21. Obenaus, E., Crudo, J., Edreira, M. et al., in 99m Tc Labelled Peptides for Imaging of Peripheral Receptors: Final Report of a Coordinated Research Project 1995–1999, Vienna (Austria): IAEA, 2001, pp. 17–27.
  22. Wang, J., Kim, Y.-S., and Liu, S., Bioconjugate Chem., 2008, vol. 19, pp. 634–642.
  23. Hirsch-Kuchma, M., Nicholson, T., Davison, A., et al., Inorg. Chem., 1997, vol. 36, no. 15, pp. 3237–3241.
  24. Liu, S., Edwards, D.S., Looby, R.J., et al., Bioconjugate Chem., 1996, vol. 7, pp. 63–71.
  25. Surfraz, M.B.-U., King, R., Mather, S.J., et al., J. Inorg. Biochem., 2009, vol. 103, pp. 971–977.
  26. Miranda-Olvera, A.D., Ferro-Flores, G., Pedraza-L贸pez, M., et al., Bioconjugate Chem., 2007, vol. 18, pp. 1560–1567.
  27. Mikolajczak, R., Markiewicz, A., and Deptula, C.Z., in 99mTc Labelled Peptides for Imaging of Peripheral Receptors: Final Report of a Coordinated Research Project 1995–1999, Vienna (Austria): IAEA, 2001, pp. 93–101.
  28. Gano, L. and Patr铆cio, L., in 99m Tc Labelled Peptides for Imaging of Peripheral Receptors: Final Report of a Coordinated Research Project 1995–1999, Vienna (Austria): IAEA, 2001, pp. 103–113.
  29. Poramatikul, N., Sangsuriyan, J., and Kongpeth, P., in 99mTc Labelled Peptides for Imaging of Peripheral Receptors: Final Report of a Coordinated Research Project 1995–1999, Vienna (Austria): IAEA, 2001, pp. 129–145.
  30. Decristoforo, C., Melendez-Alafort, L., Sosabowski, J.K., and Mather, S.J., in 99m Tc Labelled Peptides for Imaging of Peripheral Receptors: Final Report of a Coordinated Research Project 1995–1999, Vienna (Austria): IAEA, 2001, pp. 147–153.
  31. Gil, M.C., Chand铆a, V.M., and Errazu, X., in 99m Tc Labelled Peptides for Imaging of Peripheral Receptors: Final Report of a Coordinated Research Project 1995–1999, Vienna (Austria): IAEA, 2001, pp. 39–49.
  32. Mishra, A.K., Mishra, P., Chuttani, K., et al., in 99mTc Labelled Peptides for Imaging of Peripheral Receptors: Final Report of a Coordinated Research Project 1995–1999, Vienna (Austria): IAEA, 2001, pp. 49–55.
  33. Salouti, M., Rajabi, H., Babaei, M.H., and Rasaee, M.J., Nucl. Med. Biol., 2008, vol. 35, pp. 763–768.
  34. Gandomkar, M., Najafi, R., Shafiei, M., et al., Nucl. Med. Biol., 2007, vol. 34, pp. 651–657.
  35. Decristoforo, C., Santos, I., Pietzsch, H.J., et al., J. Nucl. Med. Appl. Mol. Imag., 2007, vol. 51, pp. 33–41.
  36. Qu, T., Wang, Y., Zhu, Z., et al., Nucl. Med. Commun., 2001, vol. 22, pp. 203–215.
  37. Ohtsuki, K., Akashi, K., Aoka, Y., et al., Eur. J. Nucl. Med., 1999, vol. 26, no. 10, pp. 1251–1258.
  38. Blankenberg, F.G., Katsikis, P.D., Tait, J.F., et al., J. Nucl. Med., 1999, vol. 40, pp. 184–191.
  39. Rottey, S., Loose, D., Vakaet, L., et al., J. Nucl. Med. Appl. Mol. Imag., 2007, vol. 51, pp. 182–188.
  40. Biechlin, M.-L., Bonmartin, A., Gilly, F.-N., et al., Nucl. Med. Biol., 2008, vol. 35, pp. 679–687.
  41. B茅he, M., Powell, P., and M盲cke, H.R., in 99m Tc Labelled Peptides for Imaging of Peripheral Receptors: Final Report of a Coordinated Research Project 1995–1999, Vienna (Austria): IAEA, 2001, pp. 115–128.
  42. Bangard, M., B茅h茅, M., Guhlke, S., et al., Eur. J. Nucl. Med., 2000, vol. 27, pp. 628–637.
  43. Waehrens, L.N., Rasmussen, J.T., Heegaagd, C.W., and Falborg, L., J. Label. Compd. Radiopharm., 2007, vol. 50, pp. 211–217.
  44. Hubalewska-Dydejczyk, A., Fr枚ss-Baron, K., Mikołajczak, R., et al., Eur. J. Nucl. Med. Mol. Imag., 2006, vol. 33, pp. 1123–1133.
  45. Chrapko, B.E., Nocuń, A., GoŁębiewska, B., and Stefaniak, B., Eur. J. Nucl. Med. Mol. Imag., 2009, vol. 36, suppl. 2, pp. S260–S280, OP545, S264.
  46. Liu, S., Kim, Y.-S., Hsieh, W.-Y., and Sreerama, S.G., Nucl. Med. Biol., 2008, vol. 35, no. 1, pp. 111–121.
  47. Rusckowski, M., Qu, T., and Gupta, S., J. Nucl. Med., 2001, vol. 42, pp. 1870–1877.
  48. Zhang, Y.-M., Liu, N., Zhu, Z.-H., et al., Eur. J. Nucl. Med., 2000, vol. 27, pp. 1700–1707.
• 作者单位：http://www.springerlink.com/content/d185049134l5l136/
• 刊物类别：Chemistry and Materials Science
• 刊物主题：Chemistry
  Nuclear Chemistry
  Chemistry
  Russian Library of Science
  
• 出版者：MAIK Nauka/Interperiodica distributed exclusively by Springer Science+Business Media LLC.
• ISSN：1608-3288

文摘

Today the main radionuclide used for preparing radiopharmaceuticals throughout the world is 99m Tc, thanks to its optimal nuclear-physical characteristics and ready availability. Several approaches are used for tethering this radionuclide to biomolecules (peptides, antibodies, etc.); one of them involves the use of so-called bifunctional chelating agents (BCAs). These compounds are capable both of binding 99m Tc and of linking to biomolecules. Today the most frequently used BCAs are DTPA, MAG3, and HYNIC. These BCAs are described and compared. The peptides that are most frequently used in combination with these agents are described and compared. Published data on the choice of a coligand for use in combination with HYNIC are discussed.